be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

All articles

Filters:

Show search box

2015-02-11

Tau-based vaccines as a novel tool for Alzheimer’s Disease treatment

Tau-based vaccines as a novel tool for Alzheimer’s Disease treatment

Alzheimer’s disease is the most frequent cause of dementia. Currently, there are various studies all over the world trying to elaborate efficient therapies to help patients. Among them, there are approaches associated with immunomodulation, thus application of vaccines. One of the newest idea is to t... Read more

Tags Alzheimer's disease , treatment , tau , amyloid , vaccine , ACL-35